A prolonged housing / new-construction downturn — volumes are already soft and demand is "cyclical"
One-line thesis. Sherwin-Williams is a genuinely elite, wide-moat compounder — dominant US paint distribution, ~58% ROE, decades of dividend growth — but at 33× trailing earnings on ~2% revenue growth and ~9% forward EPS growth, with a 3.0× levered balance sheet and an overbought chart that has lagged the S&P by ~21 points over a year, the price already reflects the quality. Watch; wait for a better entry.
◆ Synthos call — HoldSHW is a solid business largely reflected at ~$350 — fine to keep, no reason to chase; it gets interesting again below ~$298.
Elite ROE/ROIC & durable moat, but only ~2% top-line and ~9% forward EPS CAGR — a compounder, not a grower.
Exponential Potential
3/10 · Low
Mature megacap in a saturated NA architectural-paint market; growth decelerating — no multibagger runway.
⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 16%/yrTo justify today’s $352, earnings would have to compound roughly 16% a year for 10 years (9% discount rate). Analysts forecast ~9%/yr, so the market is pricing in MORE than what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
Sherwin-Williams is the company behind the paint stores contractors and homeowners buy from — it's the biggest paint-and-coatings seller in North America, plus a big industrial-coatings business. It's a wonderful, boring, money-printing business: it earns huge returns and has raised its dividend for decades.
The problem is the price. You're paying about 33 dollars for every 1 dollar of yearly profit, which is expensive for a company whose sales are barely growing (about 2% a year) because housing and construction are soft right now. Good company, full price. So our verdict is Watch — keep an eye on it and wait for it to get cheaper or for growth to pick up, rather than buying today.
Here's what our three scores mean in everyday terms:
Downside Risk 6/10 (a bit above average). It carries meaningful debt (about 3 years of profit) and the stock has been jumpy and expensive; a housing slump or a stumble would hurt.
Growth Quality 6/10 (good, not great). The business is extremely well-run and profitable, but it's growing slowly right now.
Exponential Potential 3/10 (low). It's already huge and in a mature market, so it won't multiply your money quickly — it compounds gently over years.
The one big worry: most of Sherwin's sales ride on painting new and existing homes and commercial buildings. If construction stays weak or gets worse, volumes fall and the expensive stock has room to drop.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLB (sector)), set to 100 a year ago
Solid = SHW · dashed = S&P 500 · dotted = XLB (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$352.48
Market cap$87B
P/E trailing15×
P/E FY26E / FY27E30× / 27×
EV / Sales4.2×
EV / EBITDA22.5×
Gross margin49.1%
Net margin10.9%
Dividend yield0.90%
Beta1.126
52-wk range$293 – $375
RSI(14)79
50 / 200-DMA$317 / $334
12-mo return+-1% (SPY +21%)
Street target$375 ($330–$410)
Analyst grades22 Buy · 15 Hold · 1 Sell
FMP ratingB
Next earnings2026-08-05
What the experts actually said 0 traceable claims on SHW · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
Sherwin-Williams (NYSE: SHW), founded 1866 and headquartered in Cleveland, is the largest paint-and-coatings company in North America. It develops, manufactures and sells paint, coatings and related products to professional, industrial, commercial and retail customers, and reports in three segments. Fiscal year ends December 31.
Paint Stores Group $13.61B — architectural paint sold through Sherwin's ~5,000+ company-owned stores to pro painters and DIY; the crown-jewel distribution moat and the profit engine.
Consumer Brands Group $8.55B — branded and private-label paint/stains sold through home centers, hardware stores and dealers (includes Valspar, Suvinil).
Performance Coatings / Global Finishes Group $6.82B — industrial, automotive-refinish, protective & marine, coil and packaging coatings.
(Corporate & eliminations −$5.41B nets these to consolidated FY25 revenue of $23.57B.)
Geography: the base is heavily US/North America; FMP flags only Non-US $4.62B for FY25 (roughly 20% of sales), so ~80% is domestic. That is a US-housing-cycle concentration — a pricing-power strength but a cyclicality risk (§11).
The strategic story is share-of-wallet and new-account growth in a soft market, digestion of the 2025 Suvinil (Brazil) acquisition, and heavy investment in a new global HQ / technology center — a self-help, execution story rather than a new-market inflection.
2. The expert thesis
There is no expert coverage of SHW in the Synthos knowledge base.total_claims = 0; there are zero net-bullish (or bearish) voices to reconcile. In keeping with the house standard, we do not manufacture conviction we don't have: no claim_id values are cited in this note because none exist for this name.
What that means for the verdict. This deep dive is fundamentals- and quant-driven only. The judgment rests on reported financials (FMP), live analyst consensus estimates (labeled as estimates), management's own SEC-filed guidance (half-weighted, §9), and our own valuation model — not on any Synthos expert panel. Treat the conviction rating as Low accordingly: a clean, honest "no signal" from the expert layer, not a hidden bearish one.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
6 · Above-average
Net-debt/EBITDA ~3.0× and beta 1.13 are not fortress-grade; 33× trailing on ~9% EPS growth is a rich PEG, RSI 79 is overbought, and ~80% US revenue ties it to the housing cycle.
Growth Quality
6 · Good
Elite returns (ROE ~58%, ROIC ~14%, ROCE ~20%) and a durable distribution moat — but only ~2% revenue growth and ~9% forward EPS CAGR. Quality is high; the rate is pedestrian.
Exponential Potential
3 · Low
A mature megacap in a saturated NA architectural-paint market, with growth decelerating. Real compounding, no multibagger runway.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. The cases bound the range, and the scores above summarize them.
Case
Key assumptions
Fair value
Bull
Housing/new-construction re-accelerates; volume growth returns on top of price; Suvinil accretes. FY28E EPS beats toward ~$15.5 and the market pays a premium ~29× for the re-acceleration.
~$450 (+28%)
Base(our anchor)
Estimates roughly hit — FY27E EPS ~$13.19; a high-quality but slow-growth compounder earns a ~26× multiple.
~$350 (~flat)
Bear
Prolonged housing downturn; volumes stay negative, price/cost squeeze, leverage bites. FY27E EPS misses toward ~$12.5 and the multiple de-rates to ~20×.
~$255 (−28%)
Synthos fair value = the base case, ~$350 (~0% from spot), with the full $255–$450 span as the honest range. Our base sits below the Street's $374.56 consensus — we are less willing to pay 30×+ for ~2% top-line growth in a soft cycle. This is a tracked call; the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers-from-here). SHW is squarely a compounder that is past any acceleration:
Forward growth: revenue CAGR FY25→FY29E ~4.6% ($23.6B → $28.2B, estimates); EPS CAGR ~9.2% ($11.37 → $16.16 on consensus, or ~12% off FY25 actual $10.27 as margins/buybacks help).
Acceleration (2nd derivative) is flat-to-negative: FY25 revenue grew only ~2%, and Q1'26 grew 6.8% only because of the Suvinil acquisition and FX — organic same-store sales were +2.4%. Management itself cites "continued demand softness in most end markets." There is no inflection here.
Room to run: North American architectural paint is a mature, saturated category; Sherwin already owns the dominant share via its store network. TAM expansion comes slowly (industrial, international, share-of-wallet), not in step-changes. At ~$87B market cap, a 3–5× would require share and margins the category can't quickly supply.
Reinvestment runway: productive but incremental — store openings, the new HQ/tech center, bolt-on M&A (Suvinil). Buybacks (~$1.66B FY25) are a real part of the EPS story, which is a sign of a mature capital-return profile, not a growth one.
Exponential Potential: Low (3/10). Own SHW, if at all, for steady high-quality compounding and dividend growth, never for a fast multibagger. This is the honest opposite of a flagship next-exponential.
Revenue: FY25 $23.57B, +2.1% (FY24 $23.10B, FY23 $23.05B). Essentially flat for three years — a soft-demand plateau.
Quarterly trajectory: Q1'25 $5.31B → Q2 $6.31B → Q3 $6.36B → Q4 $5.60B → Q1'26 $5.67B (+6.8% YoY, but boosted by Suvinil + FX; organic same-store +2.4%). Normal seasonal shape (spring/summer painting), no organic acceleration.
Margins: gross 49.1% TTM (and expanding as raw-material costs moderate), EBITDA ~18.7%, operating ~16.1%, net ~10.9%. Best-in-class for a coatings maker.
Earnings: net income $2.57B FY25, EPS diluted $10.27 (vs $10.55 FY24 — a slight dip). Q1'26 diluted EPS $2.15 (+7.5%), adjusted $2.35.
Cash flow: operating CF $3.45B FY25, capex −$0.80B, FCF ~$2.65B — a ~3.3% FCF yield at today's price. FCF comfortably funds the dividend (~$790M) and buybacks.
Balance sheet: total debt $14.5B, net debt $14.3B, net-debt/EBITDA ~3.0–3.3× — meaningfully levered (an EPS tailwind via buybacks, but a risk if the cycle turns). Book equity is thin ($4.6B) after years of buybacks, which is why ROE screens at ~58% (flattered by the small equity base). Current ratio 0.86× (below 1).
6. Valuation — priced in or room?
There is no way to call SHW cheap: 33× trailing EPS, 4.2× EV/sales, 22.5× EV/EBITDA, 19.5× book. FMP's own quant flags this — P/E score 1/5, P/B score 1/5, D/E score 1/5 (overall letter rating "B"). The bull's defense is the usual quality-compounder one — that EPS out-grows the multiple: on live consensus forward P/E compresses 30× (FY26E) → 27× (FY27E) → 22× (FY29E)if estimates hit. But with only ~9% EPS growth, the forward PEG is rich (~2.7× on FMP's forward PEG), so you're paying a full premium for durability, not growth. A reverse read: today's $352 already discounts continued flawless execution and a housing recovery that hasn't arrived. Street targets (context): consensus $374.56, high $410, low $330. Our ~$350 base is below consensus because we won't pay 30×+ for a ~2%-growth cyclical in a soft market. Not a value buy; a great-business-at-a-full-price name to Watch.
7. Technicals (from the tech block)
Trend: modestly up — $352.48 sits above the 50-DMA ($317.37) and the 200-DMA ($333.58), MACD +9.8 (positive).
Location:−6.1% off the 52-week high ($375.23), +20.3% off the 52-week low ($293.00); max drawdown from peak ~−11.8%. Mid-to-upper part of its range.
Momentum: RSI(14) 79 — overbought (>70). This is a genuine stretched-entry warning: near-term the stock has run hot.
Relative strength (the tell): SHW −0.8% 12-mo vs SPY +20.6% and QQQ +30.3% — a clear laggard over the year, even though it's outperformed short-term (+8.2% 3-mo). Persistent 12-month underperformance argues against treating this as a leadership name.
Read: technicals are mixed and cautionary — a name above its moving averages but overbought on RSI and a 12-month underperformer. No urgency to buy today; an RSI reset toward the rising 50-DMA (~$317) would be a lower-risk entry.
8. Moat & competitive position
Sherwin's moat is unusually strong for a materials company: a captive ~5,000-store distribution network that locks in professional painters (convenience, color-matching, credit, delivery, tinting) — a switching-cost and scale advantage rivals can't easily replicate — plus leading brands (Sherwin-Williams, Valspar, and now Suvinil in Brazil), pricing power, and manufacturing scale. That is why it earns ~58% ROE / ~20% ROCE and sustains gross margins near 49%. The knock is that the moat protects a mature, cyclical, low-organic-growth category rather than an expanding one.
Peer set (FMP-supplied, market cap). Note the FMP peer list is a generic "Basic Materials" bucket — the truly comparable coatings names are PPG Industries $27.9B and RPM International $14.2B (SHW at ~$87B dwarfs both and out-earns them on margin/returns). The rest are chemicals/mining and not close comps: Air Products $70.0B, Ecolab $79.7B, CRH $71.9B, plus miners BHP $211.7B, Southern Copper $143.5B, Newmont $103.6B, Freeport $87.6B, Agnico Eagle $76.9B. Within coatings, SHW is the clear quality and scale leader.
9. Management, capital allocation & guidance
Capital allocation: disciplined and shareholder-friendly — FY25 returned ~$790M in dividends (dividend yield ~0.9%, a long record of increases) and ~$1.66B in buybacks, while investing in stores, the new global HQ/tech center, and the Suvinil acquisition (~$1.21B of net acquisitions in FY25). Leverage at ~3× EBITDA is a deliberate choice to juice per-share returns — fine in good times, a constraint if the cycle turns.
Insider activity: the sampled window is mostly routine April 2026 director stock awards at $315.50 and February vesting/withholding; one officer discretionary sale (SVP Corp Strategy, ~2,513 shares at $364.47, Feb 2026). No alarming cluster — normal comp/diversification activity.
Management's own guidance (half-weighted — their self-interested words). The Q1'26 earnings release (SEC 8-K, filed 2026-04-28) reaffirmed full-year 2026 guidance: reported diluted EPS $10.70–$11.10 (including $0.80 of Valspar acquisition amortization) and adjusted diluted EPS $11.50–$11.90. CEO Heidi Petz framed the quarter as "strong sales in a quarter characterized by heightened global uncertainty and continued demand softness in most end markets," citing gross-margin expansion and a low-single-digit full-year SG&A increase (ex-Suvinil). This is management's own book — treated at half weight. It is consistent with the ~$11.72 FY26E consensus and implies the modest ~9% EPS growth our model uses.
10. Catalysts & what to watch
Next earnings: 2026-07-28 (Q2'26; Street EPS $3.52, revenue ~$6.61B). Key line: organic same-store sales in Paint Stores Group (is volume improving beyond price/FX/Suvinil?).
Housing & construction data: new-residential, residential-repaint and commercial demand — the swing factor for volumes.
Raw-material costs & gross margin: management flagged moderating raws; continued margin expansion is a real EPS lever.
Suvinil integration: Brazil acquisition accretion/dilution and FX.
Guidance revisions: any move off the reaffirmed $11.50–$11.90 adjusted-EPS range.
Thesis tripwires (what would change the call): two straight quarters of negative organic same-store sales; a guidance cut; gross margin rolling over; or leverage rising above ~3.5× EBITDA in a downturn. Conversely, a genuine housing re-acceleration plus a multiple/RSI reset toward ~$317 would flip this from Watch toward Buy.
11. Key risks
Housing / construction cyclicality (structural): ~80% US revenue tied to new construction, residential repaint and commercial demand — already soft ("continued demand softness in most end markets," per management). A prolonged downturn hits volumes directly.
Valuation / de-rating: 33× trailing on ~2% revenue and ~9% EPS growth leaves little margin for a demand or margin disappointment.
Leverage: net-debt/EBITDA ~3.0× and current ratio <1 amplify downside if EBITDA falls; interest expense (~$469M FY25) is a real drag.
Overbought technicals: RSI 79 and 12-month underperformance vs SPY/QQQ argue against chasing today.
Integration/M&A: Suvinil and other bolt-ons carry execution and FX risk; Valspar amortization still drags reported EPS by ~$0.80/yr.
12. Verdict, position sizing & monitoring
Watch. Sherwin-Williams is a genuinely elite, wide-moat compounder — dominant distribution, ~49% gross margin, ~58% ROE, decades of dividend growth, and management executing well in a soft market. But the price already reflects the quality: 33× trailing earnings on ~2% revenue and ~9% forward EPS growth, a 3.0× levered balance sheet, an overbought chart (RSI 79), and a stock that has lagged the S&P 500 by ~21 points over the past year. Our base-case fair value (~$350) sits below both the spot price and the Street's $374.56 consensus. There is no Synthos expert coverage to push conviction either way — this is a clean quant/fundamentals call.
Sizing: if owned at all, a small (~1–2%) quality-cyclical position, not a flagship core — and preferably added on weakness, not at an overbought high.
Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print. A housing re-acceleration plus a pullback toward the rising 50-DMA (~$317) would be the setup to upgrade.
Single biggest risk: a prolonged housing/new-construction downturn crushing volumes while the multiple is still full.
This verdict is logged as a tracked Synthos call as of 2026-07-03 at $352.48.
Provenance & disclosures
Traceability:0 KB claims, breadth 0 — there is no Synthos expert coverage for SHW, so no claim_ids are cited. Conviction rating is Low by construction; the verdict is fundamentals- and quant-driven only. Fabricated conviction is structurally impossible (claim-ID reconciliation).
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · no expert claims. Forward figures are analyst consensus (FMP), labeled as estimates.
Management caveat: the FY26 EPS guidance in §9 is management's own SEC-filed words (Q1'26 8-K, 2026-04-28), half-weighted by design.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").